Upstate Active Clinical Trials
Study Title:
A Phase 1/2, Randomized, Dose-finding/Dose-confirmation Study to Evaluate the Reactogenicity, Safety and Immuno genicity of mRNA-based Multivalent Season Influenza Vaccine CandidatesWhat is the purpose of the study? (in Layman's terms, please describe the study)
To study the safety and efficacy of an mRNA-based influenza vaccineUpstate Institutional Review Board (IRB) Number:
2020089Study/Protocol ID:
217884Study Phase:
2Patient Age Group:
AdultsPrincipal Investigator:
Stephen J ThomasWhat is involved if I participate?
- How long is the study?
1 year - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
Yes - What tests and procedures are involved?
Blood draws, injection with vaccine or placebo
Where will the study take place?
Institute for Global Health and Translational Science, Global Health Research Unit4900 Broad Rd, POB-North Suite 4U
Syracuse NY 13215
Other Information:
No flu vaccine yet for the 2023-24 seasonClinicalTrials.Gov ID:
NCT05823974For more information about this trial go to ClinicalTrials.Gov
Who can I contact for more information?
Name: William Gregory
Phone: 315-464-5225
Email: [email protected]